Nadolol 20 MG Oral Tablet — RxCUI 198006
RxNorm drug concept · Semantic clinical drug
RxCUI 198006
Semantic clinical drug · SCD
● Current RxNorm concept 47 FDA products
92 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198006
Official nameNadolol 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped47
Package NDCs mapped92
Reported Medicaid activity (SDUD)59,132 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nadolol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Nadolol is a beta-blocker. It is used for long-term management of angina, which is chest pain from the heart, and to treat high blood pressure. It can be used alone or with other b...
- You take nadolol by mouth, usually once a day, with or without food. Your doctor will choose and adjust your dose, so follow your label. Try to take it at the same time every day.
- No, please don't stop it suddenly. Stopping a beta-blocker abruptly can make angina worse and may even lead to a heart attack. If you need to come off it, your doctor will lower th...
- Most people have mild effects, if any. These can include a slow heartbeat, dizziness, tiredness, cold fingers and toes, or stomach upset. Call your doctor if you faint, feel wheezy...
🕸️ Concept Web — How Nadolol 20 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nadolol 20 MG Oral Tablet
RxCUI 198006 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nadolol
7226IN
-
Nadolol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Corgard
151549BN
-
Corgard
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nadolol Oral Tablet
372978SCDF -
Nadolol Oral Product
1156399SCDG -
Nadolol Pill
1156400SCDG -
Nadolol Oral Tablet [Corgard]
92254SBDF -
Corgard Oral Product
1169536SBDG -
Corgard Pill
1169537SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Nadolol Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nadolol 20 MG
316319SCDC -
Nadolol 20 MG Oral Tablet [Corgard]
206961SBD -
Nadolol 20 MG [Corgard]
567762SBDC
-
Nadolol 20 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nadolol 20 MG
SCDC · 316319 -
Nadolol Oral Tablet
SCDF · 372978 -
Nadolol Oral Product
SCDG · 1156399 -
Nadolol Pill
SCDG · 1156400
Brand-Name Concepts
-
Nadolol 20 MG Oral Tablet [Corgard]
SBD · 206961 -
Nadolol 20 MG [Corgard]
SBDC · 567762 -
Nadolol Oral Tablet [Corgard]
SBDF · 92254 -
Corgard Oral Product
SBDG · 1169536 -
Corgard Pill
SBDG · 1169537 -
Corgard
BN · 151549
📦 FDA Products & Package NDCs
47 products · 92 package NDCs
92 package NDCs map to RxCUI 198006 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 46708-0402-30 | 30 TABLET in 1 BOTTLE (46708-402-30) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0402-31 | 100 TABLET in 1 BOTTLE (46708-402-31) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0402-91 | 1000 TABLET in 1 BOTTLE (46708-402-91) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0403-30 | 30 TABLET in 1 BOTTLE (46708-403-30) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0403-31 | 100 TABLET in 1 BOTTLE (46708-403-31) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0403-91 | 1000 TABLET in 1 BOTTLE (46708-403-91) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0404-30 | 30 TABLET in 1 BOTTLE (46708-404-30) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0404-31 | 100 TABLET in 1 BOTTLE (46708-404-31) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 46708-0404-91 | 1000 TABLET in 1 BOTTLE (46708-404-91) | NADOLOL | Alembic Pharmaceuticals Limited | 2023-06-08 |
| 50090-7995-00 | 30 TABLET in 1 BOTTLE (50090-7995-0) | Nadolol | A-S Medication Solutions | 2026-06-15 |
| 50090-7995-01 | 90 TABLET in 1 BOTTLE (50090-7995-1) | Nadolol | A-S Medication Solutions | 2026-06-15 |
| 51407-0977-01 | 100 TABLET in 1 BOTTLE (51407-977-01) | Nadolol | Golden State Medical Supply, Inc. | 2025-04-01 |
| 51407-0978-01 | 100 TABLET in 1 BOTTLE (51407-978-01) | Nadolol | Golden State Medical Supply, Inc. | 2025-04-01 |
| 51407-0979-01 | 100 TABLET in 1 BOTTLE (51407-979-01) | Nadolol | Golden State Medical Supply, Inc. | 2025-04-01 |
| 59651-0251-01 | 100 TABLET in 1 BOTTLE (59651-251-01) | Nadolol | Aurobindo Pharma Limited | 2021-10-29 |
| 59651-0252-01 | 100 TABLET in 1 BOTTLE (59651-252-01) | Nadolol | Aurobindo Pharma Limited | 2021-10-29 |
| 59651-0589-01 | 100 TABLET in 1 BOTTLE (59651-589-01) | Nadolol | Aurobindo Pharma Limited | 2022-06-07 |
| 60687-0887-21 | 30 BLISTER PACK in 1 CARTON (60687-887-21) / 1 TABLET in 1... | Nadolol | American Health Packaging | 2025-10-09 |
| 60687-0898-21 | 30 BLISTER PACK in 1 CARTON (60687-898-21) / 1 TABLET in 1... | Nadolol | American Health Packaging | 2025-10-08 |
| 62332-0402-30 | 30 TABLET in 1 BOTTLE (62332-402-30) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0402-31 | 100 TABLET in 1 BOTTLE (62332-402-31) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0402-91 | 1000 TABLET in 1 BOTTLE (62332-402-91) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0403-30 | 30 TABLET in 1 BOTTLE (62332-403-30) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0403-31 | 100 TABLET in 1 BOTTLE (62332-403-31) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0403-91 | 1000 TABLET in 1 BOTTLE (62332-403-91) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0404-30 | 30 TABLET in 1 BOTTLE (62332-404-30) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0404-31 | 100 TABLET in 1 BOTTLE (62332-404-31) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 62332-0404-91 | 1000 TABLET in 1 BOTTLE (62332-404-91) | NADOLOL | Alembic Pharmaceuticals Inc. | 2023-06-08 |
| 68001-0317-00 | 100 TABLET in 1 BOTTLE (68001-317-00) | Nadolol | BluePoint Laboratories | 2017-01-31 |
| 68001-0318-00 | 100 TABLET in 1 BOTTLE (68001-318-00) | Nadolol | BluePoint Laboratories | 2017-01-31 |
| 68001-0319-00 | 100 TABLET in 1 BOTTLE (68001-319-00) | Nadolol | BluePoint Laboratories | 2017-01-31 |
| 68001-0630-00 | 100 TABLET in 1 BOTTLE (68001-630-00) | Nadolol | BluePoint Laboratories | 2025-03-01 |
| 68001-0631-00 | 100 TABLET in 1 BOTTLE (68001-631-00) | Nadolol | BluePoint Laboratories | 2025-02-24 |
| 68001-0632-00 | 100 TABLET in 1 BOTTLE (68001-632-00) | Nadolol | BluePoint Laboratories | 2025-03-05 |
| 68001-0690-00 | 100 TABLET in 1 BOTTLE (68001-690-00) | Nadolol | BluePoint Laboratories | 2026-03-17 |
| 68001-0691-00 | 100 TABLET in 1 BOTTLE (68001-691-00) | Nadolol | BluePoint Laboratories | 2026-03-30 |
| 68001-0692-00 | 100 TABLET in 1 BOTTLE (68001-692-00) | Nadolol | BluePoint Laboratories | 2026-02-25 |
| 68382-0732-01 | 100 TABLET in 1 BOTTLE (68382-732-01) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0732-10 | 1000 TABLET in 1 BOTTLE (68382-732-10) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0732-16 | 90 TABLET in 1 BOTTLE (68382-732-16) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0732-77 | 10 BLISTER PACK in 1 CARTON (68382-732-77) / 1 TABLET in 1... | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0733-01 | 100 TABLET in 1 BOTTLE (68382-733-01) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0733-10 | 1000 TABLET in 1 BOTTLE (68382-733-10) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0733-16 | 90 TABLET in 1 BOTTLE (68382-733-16) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0733-77 | 10 BLISTER PACK in 1 CARTON (68382-733-77) / 1 TABLET in 1... | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0734-01 | 100 TABLET in 1 BOTTLE (68382-734-01) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0734-10 | 1000 TABLET in 1 BOTTLE (68382-734-10) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0734-16 | 90 TABLET in 1 BOTTLE (68382-734-16) | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 68382-0734-77 | 10 BLISTER PACK in 1 CARTON (68382-734-77) / 1 TABLET in 1... | Nadolol | Zydus Pharmaceuticals USA Inc. | 2017-08-08 |
| 69097-0867-02 | 30 TABLET in 1 BOTTLE (69097-867-02) | Nadolol | Cipla USA Inc. | 2016-02-23 |
Observed labelers:
Zydus Lifesciences Limited (12) ·
Zydus Pharmaceuticals USA Inc. (12) ·
Alembic Pharmaceuticals Inc. (9) ·
Alembic Pharmaceuticals Limited (9) ·
Amneal Pharmaceuticals NY LLC (9) ·
BluePoint Laboratories (9)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.